5
Lambert-Eaton肌无力综合征.doc
Lambert-Eaton肌无力综合征 疾病别名: 肌无力样综合征,Lambert-Eaton 综合征,朗-伊二氏综合征 简述 Lambert-Eaton 肌无力综合征,(Lambert-Eaton
44
神经肌接头病-重症肌无力Lambert-Eaton 综合征.ppt
neuromusculartransmission)重症肌无力Lambert-Eaton 综合征Dep. NeurologyThe2nd Hospital Harbin Medical Univers
3
肿瘤性与非肿瘤性lambert-eaton肌无力综合征的鉴别诊断.pdf
32.[13]Baguley IJ, Cameron ID, Green AM, et al.Brain Inj, 2004, 18:409.[14] Dworkin RH, O'Connor AB,
36
中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场占有率及投资前景预测分析报告.pdf
中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场占有率及投资前景预测分析报告中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场占有率及投资前景预测分析报告中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场占有率及投资前景预测分析报告
45
神经肌接头病-重症肌无力lambert-eaton 综合征.ppt
神经肌接头病(Disorders neuromusculartransmission)重症肌无力Lambert-Eaton 综合征Dep. NeurologyThe2nd Hospital Harbi
26
博研咨询:中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场前景预测及投资价值评估分析报告.pdf
博研咨询:中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场前景预测及投资价值评估分析报告博研咨询:中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场前景预测及投资价值评估分析报告博研咨询:中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场前景预测及投资价值评估分析报告
36
population pharmacokineticspharmacodynamics of 3,4-diaminopyridine free base in patients with lambert-eaton myasthenia.[2017][cpt pharmacometrics s.pdf
population pharmacokineticspharmacodynamics of 3,4-diaminopyridine free base in patients with lambert-eaton myasthenia.[2017][cpt pharmacometrics s
32
3,4-diaminopyridine base effectively treats the weakness of lambert-eaton myasthenia.[2017][muscle nerve][10.1002mus.26052].pdf
3,4-diaminopyridine base effectively treats the weakness of lambert-eaton myasthenia.[2017][muscle nerve][10.1002mus.26052]
3
癌性Lambert-Eaton综合征1例及相关文献复习.doc
癌性Lambert—Eaton综合征1例及相关文献复习癌性Lambert—Eaton综合征1例及相关文献复习癌性Lambert—Eaton综合征1例及相关文献复习
15
中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场竞争格局及市场占有率分析报告.pdf
中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场竞争格局及市场占有率分析报告中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场竞争格局及市场占有率分析报告中国Lambert-Eaton重症肌无力综合症(LEMS)治疗行业市场竞争格局及市场占有率分析报告

向豆丁求助:有没有Lambert-Eaton?

如要投诉违规内容,请联系我们按需举报;如要提出意见建议,请到社区论坛发帖反馈。